Home
About
Overview
Sharing Data
ORCID
Help
History (2)
A dual apolipoprotein C-II mimetic-apolipoprotein C-III antagonist peptide lowers plasma triglycerides.
Outcomes among black patients with stage II and III colon cancer receiving chemotherapy: an analysis of ACCENT adjuvant trials.
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
A dual apolipoprotein C-II mimetic-apolipoprotein C-III antagonist peptide lowers plasma triglycerides.
A dual apolipoprotein C-II mimetic-apolipoprotein C-III antagonist peptide lowers plasma triglycerides. Sci Transl Med. 2020 01 29; 12(528).
View in:
PubMed
subject areas
Animals
Apolipoprotein C-II
Apolipoprotein C-III
Disease Models, Animal
Female
Half-Life
Humans
Hypertriglyceridemia
Lipolysis
Lipoprotein Lipase
Male
Mice, Inbred C57BL
Molecular Dynamics Simulation
Peptides
Primates
Triglycerides
authors with profiles
Michael H. Davidson